Please login to the form below

Not currently logged in

Ad Lib blog

Creative critiques of pharma and healthcare ads and campaigns

Picture this: Photography and pharma advertising

Kevin Stokes flags up three campaigns that provide a perfect union of “mad creative, cool photography, and crazy CGI skills” 

Advertising photography has become inseparable from digital manipulation. 

This statement is by no means meant to diminish the importance of the skills of a professional photographer. I'm simply stating that 99.9 per cent of advertising photography will at some point be manipulated or changed from the original pixels captured by the camera's sensor. 

It's just the nature of the creative business. Every photographer accepts that his or her images will be colour corrected, cropped, composited, CMYK converted, or 'digitally enhanced' in some way. Particularly in the case of more complex visual ideas, photography may only be a small part of a larger digital composition image or computer generated image (CGI). 

As a creative director (and photography enthusiast), I appreciate the subtleties of lighting, composition, exposure, and speed settings—all building blocks of a good photograph. But, sometimes you just can't capture in camera that wacky idea that you have in your head—Wacom pen-wielding digital artist to the rescue! 

You want a saw blade to burst out of the spine of a cancer pain sufferer? No problem. Can you merge human limbs together? Simple enough. Anything you can imagine can be brought to life. 

Armed with the joint skills of a well-chosen and highly gifted photographer and a masterful digital artist, advertising creatives are capable of producing communications that elicit dramatic visceral reactions, tell the brand story in fresh and intriguing ways, and begin to reshape our expectations of what we can do in pharma marketing. 

A word of caution: overuse of these weapons can have the opposite effect as well, producing a confusing, over-busy execution that clouds the communication. 
I have chosen three examples of what I consider to represent the perfect union of mad creative, cool photography, and crazy CGI skills. Enjoy.

Nycomed: Breakthrough Cancer Pain



Nycomed: Breakthrough Cancer Pain

This is an excellent example of combining photography and digital manipulation to create a visceral retina-jarring piece that communicates pain, plain and simple. This idea could have backfired and just ended up as a horror show, but skillful art direction has kept it tasteful without losing the impact.

Children’s Panadol: Their pain is your pain



Children’s Panadol: Their pain is your pain

This ad works well on a couple of levels: (1) It taps directly into the psyche by exploiting the parental instinct to protect and nurture her offspring. (2) With subtle and clever use of digital manipulation, their pain becomes one shared experience by merging hands and mirroring expressions. Clever, simple, and effective. 

Sargam: For better digestion



Sargam: For better digestion

I’ve included this ad not because it showcases an incredible feat of digital wizardry, but because it’s a perfect example of less is more. Take one beautiful female model with a digestive problem and add strategically placed bubbles to create a hilarious, but effective message in a classic problem/solution ad. Excuse me.

Article by
Kevin Stokes

VP creative director of art, Kane & Finkel Healthcare Communications

5th October 2012


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...